| Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in
Postmarketing experience and the literature suggest a greater frequency of reports of ONJ based on tumor type (advanced breast cancer, multiple myeloma) and dental status (dental extraction, periodontal disease, local trauma, including poorly fitting dentures). Many reports of ONJ involved patients with signs of local infection, including osteomyelitis. Cancer patients should maintain good oral hygiene and should have a dental examination with preventive dentistry prior to treatment with bisphosphonates. While on treatment, these patients should avoid invasive dental procedures, if possible. No data are available as to whether discontinuation of bisphosphonate therapy reduces the risk of ONJ in patients requiring dental procedures. A causal relationship between bisphosphonate use and ONJ has not been established.
FDA Approves Prostate Cancer Drug
The Food and Drug Administration has approved a new drug to fight the prostate cancer. The Food and Drug Administration has approved a new drug to fight the prostate cancer. Peoria physician Dr. Joseph Banno of Midwest Urological says it holds new promise for those suffering from the late stages of the disease. The new treatment for prostate cancer involves a drug called degarelix. Over the last decade, more and more cases of prostate cancer have been found relatively early...and are treatable through radiation and chemotherapy. But—for a minority –the disease is discovered in its late stages. That's where degarelix, pronounced day–guh–RELL–ix,offers some new hope. Prostate cancer is known to grow in the presence of testosterone, so suppression of testosterone has been a treatment goal for advanced prostate cancer for many years.
Paper Reveals Potential New Treatment for Ovarian Cancer
New effective therapies for the treatment of advanced stage ovarian cancer are urgently needed.A paper published February 9, 2009, in the Proceedings of the National Academy of Sciences (PNAS) by Dr. Janet Sawicki, Professor at the Lankenau Institute for Medical Research (LIMR), a team headed by Daniel G. Anderson, Ph.D. and Robert Langer, Sc.D. of the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) and David Bumcrot, Director of Research at Alnylam Pharmaceuticals, shows that a new therapy suppresses ovarian tumor growth and metastasis in preclinical studies.Ovarian tumors highly express two proteins, claudin-3 and -4. These proteins are associated with both an increase is cellular motility and survival of ovarian tumor cells. Claudin-3 is also over expressed in breast and prostate tumors.
Mustangs win big in front of 900-plus fans
Forty-five hundred dollars was raised for the Julie Rogers' Gift of Life program, which proves free mammograms and prostate cancer screenings for medically underserved Southeast Texas residents, according to its' Web site.
Pink, the color associated with raising breast cancer awareness, was visible throughout the arena as players wore pink head bands and Tucker wore a pink jacket while coaching.
The fans joined in on the action wearing pink shirts with the "Slam Dunk for a Cure" logo on them.
Kenneth Pleasant, the Mustangs marketing and sales director, said the crowd was among the largest of the season.
He said the largest crowd came when the Mustangs drew 1,544 people for an exhibition game earlier in the season. He added there have also been two games where Mustangs have drawn more than 1,000 people.
Early detection key to surviving prostate cancer
Portee's brother, Wayne, is also a prostate cancer survivor. "Ramon had it first. Then I started having trouble. I didn't think it would happen to me. It did."I had surgery in April 2001. In 2003, I had 39 radiation treatments. Tell every guy you know to take a test."Take the Portees' advice and take the opportunity for free prostate screening, being offered from noon to 3 p.m. Saturday in Elks Lakeview Lodge 1132, 1080 S. Franklin St. It's sponsored by the Emanon Club and the Macon County Health Department.It's the first time the Lakeview Elks Lodge has entered the prostate screening campaign, John Wilder said. He is the club's assistant social chairman and is a three-year prostate cancer survivor.Another survivor, Jerry Smalling, a retired high school coach, said he had radical prostate surgery in 1998.
FDA Approves Prostate Cancer Drug
The Food and Drug Administration has approved a new drug to fight the prostate cancer. The Food and Drug Administration has approved a new drug to fight the prostate cancer. Peoria physician Dr. Joseph Banno of Midwest Urological says it holds new promise for those suffering from the late stages of the disease. The new treatment for prostate cancer involves a drug called degarelix. Over the last decade, more and more cases of prostate cancer have been found relatively early...and are treatable through radiation and chemotherapy. But—for a minority –the disease is discovered in its late stages. That's where degarelix, pronounced day–guh–RELL–ix,offers some new hope. Prostate cancer is known to grow in the presence of testosterone, so suppression of testosterone has been a treatment goal for advanced prostate cancer for many years.
Clark Howard’s diagnosis highlights prostate cancer
Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. > The American Cancer Society estimates that 28,660 men in the United States died of prostate cancer in 2008. > Prostate cancer accounts for about 10 percent of cancer-related deaths in men. Source: American Cancer Society Questions to ask if you've been diagnosed: > What are the chances that the cancer has spread beyond my prostate? If so, is it still curable? > What further tests, if any, do you recommend, and why? > What is the clinical stage and Gleason score, or grade, of my cancer? What do those mean in my case? > What is my expected survival rate based on clinical stage, grade and various treatment options? > Should I consider watchful waiting as an option? Why or why not? > Do you recommend a radical prostatectomy or radiation? Why or why not? > If you recommend radical prostatectomy, will it be nerve sparing? > Should I consider laparoscopic or robot-assisted prostatectomy? > What types of radiation therapy might work best for me? > What other treatments might be right for me? Why? > Among those treatments, what are the risks or side effects that I should expect? > What are the chances that I will have problems with incontinence or impotence? > What are the chances that I will have other urinary or rectal problems? > What are the chances of recurrence of my cancer with the treatment programs we have discussed? What would be our next step if this happened? > Should I follow a special diet? Source: American Cancer Society .
AP Political NewsBrief at 6:11 am EST
How to help patients make wiser health choices WASHINGTON (AP) _ It's one of medicine's uncomfortable truths: That blood test for prostate cancer is far from perfect. Would as many men take a PSA test if they knew? Or consider treatment for early breast cancer: Is saving the breast worth all the extra doctor visits for radiation or would you prefer the whole breast removed in one trip? This is a news service of Thomson Business Intelligence Service ©2006. This content is for your personal use only, subject to Terms and Conditions. No redistribution allowed.
.
First Genome-wide Expression Analysis Yields Better Understanding
Most cancer treatments today fail to attack cancer at its root, which is why the disease can recur despite aggressive therapy. Before the development of cancer stem cell therapies can take place, however, scientists must improve our understanding of the similarities and differences between biological networks active in leukemic stem cells and their normal cell counterparts The PNAS paper showed that by using modern microarray technology, scientists could reveal a swath of stem-cell pathways – some of which were already well known and others not previously implicated in leukemia and other cancers. In fact, researchers identified 3,005 differentially expressed genes. Among them, a ribosome and T-cell receptor signaling pathway emerged as new players in the regulation of cancer stem cells.
Proton therapy fights cancer: Dublin prostate patient treated
Prostate cancer can be treated several ways, including surgery and radiation. Zuber said the treatment methods he researched, including proton therapy, had similar results in getting rid of cancer. "But I looked at the side effects of proton therapy, and they were less," said Zuber, of Dublin. "To me, it was just a matter of identifying where I could be treated." The nonprofit center in Florida opened in 2006 and cost $125 million to build. About 115 patients are treated there daily and 75 percent have prostate cancer, said Stuart Klein, executive director of the center. Most patients stay for two months, and about 25 percent travel from outside the southeastern United States. Zuber received 39 treatments -- one a day, Monday through Friday -- from May 5 to July 1 at a cost of $2,763 for each session.
|
